BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

News   Aug 11, 2017

 
BellBrook Labs Launches Methyltransferase Assay to Accelerate Epigenetic Drug Discovery

Methyltransferases have become a major focus of drug discovery for cancer and other diseases driven by epigenetic factors. BellBrook Labs’ new, ultra-sensitive AptaFluor™ SAH Methyltransferase Assay eliminates cost and sensitivity barriers that are slowing the discovery of methyltransferase inhibitors. Credit: BellBrook Labs

 
 
 
 

RELATED ARTICLES

Freedom of Information Request Reveals Benefits of Blocked MS Drug

News

A drug that is blocked by the EU regulatory system has now been found to improve the quality of life of people with multiple sclerosis (MS), according to a study by Queen Mary University of London (QMUL).

READ MORE

Test Successfully Identifies Which Research Results in Mice Will Help Humans With MS

News

In determining which genes are conserved across species, the researchers also discovered a new gene that improves myelin repair.

READ MORE

Stem Cells From Young Hearts Could Rejuvenate Old Hearts

News

Cardiac stem cell infusions could someday help reverse the aging process in the human heart, making older ones behave younger, according to a new study from the Cedars-Sinai Heart Institute.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Genomics Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE